USPTO serial 86925652
HLS
Reviewed by CopyMark Law Group
Reg. 5796691Status 710
- Filing date
- Status date
- Registration date
- Jul 9, 2019
- Examiner
- GUSTASON, ANNE C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with HLS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Toronto, Ontario, CA
Toronto, Ontario, CA
Toronto, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Megan K. Bowen
MEGAN K. BOWEN MORGAN, LEWIS & BOCKIUS LLP1111 PENNSYLVANIA AVENUE, NWATTN: TMSUWASHINGTON, DC 20004Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes, cardiovascular disorders, central nervous system (CNS) disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, respiratory, gastrointestinal and other metabolic disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, osteoporosis and other bone disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, immunomodulatory diseases, namely, autoimmune diseases, immunologic deficiency syndromes; and antidepressants, antivirals, antibacterial pharmaceuticals, antifungal preparations, anti-inflammatories, analgesics and other pain therapeutics, namely, pain relief medications in the nature of muscle relaxants, anti-anxiety and anti-convulsion medications and acetaminophen, pharmaceutical preparations to treat diseases of the genitourinary system in women, hormones, namely, progesterone, progestins, and estrogens, hormone receptor modulators, and osteoporosis medicines | SECTION 8 - CANCELLED | — |
| 042 | Pharmaceutical drug formulation development; clinical evaluation and testing in the nature of conducting clinical trials relating to pharmaceuticals | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HLS Therapeutics Inc.
- Other trademarks owned by HLS Therapeutics Inc.
- Other trademarks owned by HLS Therapeutics Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named HLS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 23, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Sep 10, 2025 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jul 9, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 9, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 4, 2019 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Jun 4, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 20, 2019 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| May 20, 2019 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Apr 13, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 11, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 11, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 11, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 16, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 21, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 21, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 1, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 17, 2018 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jul 13, 2018 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jul 9, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 9, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 9, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 9, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 9, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 11, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 11, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 11, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 22, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 15, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 21, 2017 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jul 21, 2017 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jul 21, 2017 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jul 20, 2017 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 19, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 19, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 19, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 19, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 19, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 13, 2017 | ALIE | ASSIGNED TO LIE | — |
| Dec 15, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 17, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 16, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 15, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 8, 2016 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Mar 7, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 5, 2016 | NWAP | NEW APPLICATION ENTERED | — |